期刊文献+

锯叶棕果实提取物联合左氧氟沙星治疗Ⅲ_A型前列腺炎的临床观察 被引量:2

Clinical Observation of Saw Palmetto Fruit Extract Combined with Levofloxacin in the Treatment of Ⅲ_A Prostatitis
原文传递
导出
摘要 目的:观察锯叶棕果实提取物联合左氧氟沙星对ⅢA型前列腺炎的临床疗效和安全性。方法:选取2012年1-12月到我院门诊就诊的ⅢA型前列腺炎患者126例,按随机数字表法分为治疗组和对照组,每组63例。治疗组采用锯叶棕果实提取物软胶囊联合左氧氟沙星片治疗,对照组单纯采用左氧氟沙星片治疗,疗程均为6周。比较两组患者慢性前列腺炎症状指数(NIH-CPSI)评分、前列腺液常规检查结果、临床疗效及不良反应。结果:治疗6周后,两组NIH-CPSI评分和白细胞数量均较治疗前下降,差异有统计学意义(P<0.05);且治疗组较对照组下降得更多,组间比较差异有统计学意义(P<0.05)。治疗组总有效率为84.1%,对照组总有效率为66.7%,差异有统计学意义(P<0.05)。两组均未记录到严重不良反应。结论:锯叶棕果实提取物软胶囊联合左氧氟沙星片治疗ⅢA型前列腺炎疗效确切,可作为选择性治疗方案之一。 OBJECTIVE:To observe the clinical efficacy and safety of Saw palmetto fruit extract combined with levofloxacin in the treatment of ⅢA prostatits. METHODS:Totally 126 patients with ⅢA prostatits from the outpatient of our hospital from Jan.to Dec. 2012 were treatment group(n=63)and control group(n=63)by random numble table. Treatment group was given Saw palmetto fruit extract soft capsules combined with Levofloxacin tablets,control group was only given Levofloxacin tablets for 6weeks. The clinic data was compared,including NIH-chronic prostatitis symptom index(NIH-CPSI)scores,routine examination results of expressed prostatic secretions,clinical efficacy and adverse reactions. RESULTS:After 6 weeks treatment,the NIH-CPSI scores and leukocyte counts in 2 groups were decreased than before,with significant difference(P〈0.05);treatment group was decreased more than control group,there was significant difference between 2 groups(P〈0.05). The total effective rate of 2 groups was respectively 84.1% and 66.7%,with significant difference(P〈0.05). There were no adverse reactions. CONCLUSIONS:Saw palmetto fruit extract soft capsules combined with Levofloxacin tablets have curative efficacy in the treatment of ⅢAprostatits and can be used as one of optional regimens.
出处 《中国药房》 CAS 北大核心 2015年第11期1529-1531,共3页 China Pharmacy
关键词 ⅢA型前列腺炎 锯叶棕果实提取物 左氧氟沙星 临床疗效 ⅢA prostatits Saw palmetto fruit extract Levofloxacin Clinical efficacy
  • 相关文献

参考文献5

二级参考文献90

  • 1沈柏华,金晓东,蔡松良,陈军,陈戈明,赵伟平,孙欣.α1受体阻滞剂联合抗生素治疗慢性前列腺炎疗效及机制[J].中华男科学杂志,2004,10(7):518-520. 被引量:57
  • 2张钧,郭震洲,王立强,任守英.药物经济学概述及在我国运用的几点设想[J].中国药房,1993,4(5):11-13. 被引量:94
  • 3王鋆,张钧.药物经济学成本-效果分析[J].药学实践杂志,1995,13(4):193-197. 被引量:462
  • 4李宏军,李汉忠,商学军,黄宇烽.α受体阻滞剂治疗Ⅲ型前列腺炎的效果分析[J].中华泌尿外科杂志,2006,27(6):424-427. 被引量:51
  • 5Roehrborn CG, Rosen RC. Medical therapy options for aging men with benign prostatic hyperplasia: focus on alfusozin 10 mg once daily. Chn Interv Aging 2008; 3: 511-24. 被引量:1
  • 6Lepor H, Williford WO, Barry MJ, Brawer MK, Dixon CM, Gormley G, et al. The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group. N Engl J Med 1996; 335: 533-9. 被引量:1
  • 7Ernst E. The risk-benefit profile of commonly used herbal therapies: Ginkgo, St John's Wort, Ginseng, Echinacea, Saw palmetto, and Kava. Ann Intern Med 2002; 136: 42-53. 被引量:1
  • 8Wilt TJ, Ishani A, Stark G, MacDonald R, Lau J, Mulrow C. Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review. JAMA 1998; 280: 1604-9. 被引量:1
  • 9Lowe FC, Ku JC. Phytotherapy in treatment of benign prostatic hyperplasia: a critical review. Urology 1996; 48: 12-20. 被引量:1
  • 10Koch E. Extracts from fruits of saw palmetto (Sabal serrulata) and roots of stinging nettle (Urtica dioica): viable alternatives in the medical treatment of benign prostatic hyperplasia and associated lower urinary tracts symptoms. Planta Med 2001; 67: 489-500. 被引量:1

共引文献47

同被引文献34

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部